The Oxford Healthcare Values Partnership: Recent Episodes
Oxford University
The Healthcare Values Partnership is led by Professor Joshua Hordern of the University of Oxford who collaborates with a range of colleagues in Oxford and elsewhere. The ethos of the partnership is to develop working relationships between patients, researchers, healthcare practitioners, managers and policy makers to explore questions of value in healthcare today. We welcome new conversations and partners who share this focus.
http://www.healthcarevalues.ox.ac.uk
Session 4: Equity and commissioning - Richard Sullivan A major conference exploring scientific, clinical, legal, ethical and social implications of biomarker-based personalised medicine. Speakers include Richard Barker (Centre for the Advancement of Sustainable Medical Innovation, Oxford), Steve Sturdy (Professor of the Sociology of Medical Knowledge, University of Edinburgh), Sian Rees (Oxford Academic Health Science Network; Director, Oxford Health Experiences Institute), Anna Middleton (Wellcome Trust Sanger Institute), Muir Gray (Better Value Healthcare), Alastair Kent (Genetic Alliance, UK).
Session 4: Equity and commissioning - Muir Gray A major conference exploring scientific, clinical, legal, ethical and social implications of biomarker-based personalised medicine. Speakers include Richard Barker (Centre for the Advancement of Sustainable Medical Innovation, Oxford), Steve Sturdy (Professor of the Sociology of Medical Knowledge, University of Edinburgh), Sian Rees (Oxford Academic Health Science Network; Director, Oxford Health Experiences Institute), Anna Middleton (Wellcome Trust Sanger Institute), Muir Gray (Better Value Healthcare), Alastair Kent (Genetic Alliance, UK).
Session 3: Data sharing and participation - Jonathan Montgomery A major conference exploring scientific, clinical, legal, ethical and social implications of biomarker-based personalised medicine. Speakers include Richard Barker (Centre for the Advancement of Sustainable Medical Innovation, Oxford), Steve Sturdy (Professor of the Sociology of Medical Knowledge, University of Edinburgh), Sian Rees (Oxford Academic Health Science Network; Director, Oxford Health Experiences Institute), Anna Middleton (Wellcome Trust Sanger Institute), Muir Gray (Better Value Healthcare), Alastair Kent (Genetic Alliance, UK).
Session 3: Data sharing and participation - Anna Middleton A major conference exploring scientific, clinical, legal, ethical and social implications of biomarker-based personalised medicine. Speakers include Richard Barker (Centre for the Advancement of Sustainable Medical Innovation, Oxford), Steve Sturdy (Professor of the Sociology of Medical Knowledge, University of Edinburgh), Sian Rees (Oxford Academic Health Science Network; Director, Oxford Health Experiences Institute), Anna Middleton (Wellcome Trust Sanger Institute), Muir Gray (Better Value Healthcare), Alastair Kent (Genetic Alliance, UK).
Session 3: Data sharing and participation - Mark Lawler A major conference exploring scientific, clinical, legal, ethical and social implications of biomarker-based personalised medicine. Speakers include Richard Barker (Centre for the Advancement of Sustainable Medical Innovation, Oxford), Steve Sturdy (Professor of the Sociology of Medical Knowledge, University of Edinburgh), Sian Rees (Oxford Academic Health Science Network; Director, Oxford Health Experiences Institute), Anna Middleton (Wellcome Trust Sanger Institute), Muir Gray (Better Value Healthcare), Alastair Kent (Genetic Alliance, UK).
Session 2: The human person and the communication of risk - Sian Rees A major conference exploring scientific, clinical, legal, ethical and social implications of biomarker-based personalised medicine. Speakers include Richard Barker (Centre for the Advancement of Sustainable Medical Innovation, Oxford), Steve Sturdy (Professor of the Sociology of Medical Knowledge, University of Edinburgh), Sian Rees (Oxford Academic Health Science Network; Director, Oxford Health Experiences Institute), Anna Middleton (Wellcome Trust Sanger Institute), Muir Gray (Better Value Healthcare), Alastair Kent (Genetic Alliance, UK).
Session 2: The human person and the communication of risk - Alastair Kent A major conference exploring scientific, clinical, legal, ethical and social implications of biomarker-based personalised medicine. Speakers include Richard Barker (Centre for the Advancement of Sustainable Medical Innovation, Oxford), Steve Sturdy (Professor of the Sociology of Medical Knowledge, University of Edinburgh), Sian Rees (Oxford Academic Health Science Network; Director, Oxford Health Experiences Institute), Anna Middleton (Wellcome Trust Sanger Institute), Muir Gray (Better Value Healthcare), Alastair Kent (Genetic Alliance, UK).
Session 2: The human person and the communication of risk - Joshua Hordern A major conference exploring scientific, clinical, legal, ethical and social implications of biomarker-based personalised medicine. Speakers include Richard Barker (Centre for the Advancement of Sustainable Medical Innovation, Oxford), Steve Sturdy (Professor of the Sociology of Medical Knowledge, University of Edinburgh), Sian Rees (Oxford Academic Health Science Network; Director, Oxford Health Experiences Institute), Anna Middleton (Wellcome Trust Sanger Institute), Muir Gray (Better Value Healthcare), Alastair Kent (Genetic Alliance, UK).
Session 1: The promise and the hype of 'personalised medicine' - John Tooke A major conference exploring scientific, clinical, legal, ethical and social implications of biomarker-based personalised medicine. Speakers include Richard Barker (Centre for the Advancement of Sustainable Medical Innovation, Oxford), Steve Sturdy (Professor of the Sociology of Medical Knowledge, University of Edinburgh), Sian Rees (Oxford Academic Health Science Network; Director, Oxford Health Experiences Institute), Anna Middleton (Wellcome Trust Sanger Institute), Muir Gray (Better Value Healthcare), Alastair Kent (Genetic Alliance, UK).
Session 1: The promise and the hype of 'personalised medicine' - Steve Sturdy A major conference exploring scientific, clinical, legal, ethical and social implications of biomarker-based personalised medicine. Speakers include Richard Barker (Centre for the Advancement of Sustainable Medical Innovation, Oxford), Steve Sturdy (Professor of the Sociology of Medical Knowledge, University of Edinburgh), Sian Rees (Oxford Academic Health Science Network; Director, Oxford Health Experiences Institute), Anna Middleton (Wellcome Trust Sanger Institute), Muir Gray (Better Value Healthcare), Alastair Kent (Genetic Alliance, UK).
Session 1: The promise and the hype of 'personalised medicine' - Tim Maughan A major conference exploring scientific, clinical, legal, ethical and social implications of biomarker-based personalised medicine. Speakers include Richard Barker (Centre for the Advancement of Sustainable Medical Innovation, Oxford), Steve Sturdy (Professor of the Sociology of Medical Knowledge, University of Edinburgh), Sian Rees (Oxford Academic Health Science Network; Director, Oxford Health Experiences Institute), Anna Middleton (Wellcome Trust Sanger Institute), Muir Gray (Better Value Healthcare), Alastair Kent (Genetic Alliance, UK).
Highlights of Personalised Medicine: the promise, the hype and the pitfalls A major conference exploring scientific, clinical, legal, ethical and social implications of biomarker-based personalised medicine. Speakers include Richard Barker (Centre for the Advancement of Sustainable Medical Innovation, Oxford), Steve Sturdy (Professor of the Sociology of Medical Knowledge, University of Edinburgh), Sian Rees (Oxford Academic Health Science Network; Director, Oxford Health Experiences Institute), Anna Middleton (Wellcome Trust Sanger Institute), Muir Gray (Better Value Healthcare), Alastair Kent (Genetic Alliance, UK).
Personalised Medicine: the promise, the hype and the pitfalls, a short interview with Jonathan Montgomery A major conference exploring scientific, clinical, legal, ethical and social implications of biomarker-based personalised medicine. Speakers include Richard Barker (Centre for the Advancement of Sustainable Medical Innovation, Oxford), Steve Sturdy (Professor of the Sociology of Medical Knowledge, University of Edinburgh), Sian Rees (Oxford Academic Health Science Network; Director, Oxford Health Experiences Institute), Anna Middleton (Wellcome Trust Sanger Institute), Muir Gray (Better Value Healthcare), Alastair Kent (Genetic Alliance, UK).
Personalised Medicine: the promise, the hype and the pitfalls, a short interview with Anna Middleton A major conference exploring scientific, clinical, legal, ethical and social implications of biomarker-based personalised medicine. Speakers include Richard Barker (Centre for the Advancement of Sustainable Medical Innovation, Oxford), Steve Sturdy (Professor of the Sociology of Medical Knowledge, University of Edinburgh), Sian Rees (Oxford Academic Health Science Network; Director, Oxford Health Experiences Institute), Anna Middleton (Wellcome Trust Sanger Institute), Muir Gray (Better Value Healthcare), Alastair Kent (Genetic Alliance, UK).
Personalised Medicine: the promise, the hype and the pitfalls, a short interview with Marion Lynch A major conference exploring scientific, clinical, legal, ethical and social implications of biomarker-based personalised medicine. Speakers include Richard Barker (Centre for the Advancement of Sustainable Medical Innovation, Oxford), Steve Sturdy (Professor of the Sociology of Medical Knowledge, University of Edinburgh), Sian Rees (Oxford Academic Health Science Network; Director, Oxford Health Experiences Institute), Anna Middleton (Wellcome Trust Sanger Institute), Muir Gray (Better Value Healthcare), Alastair Kent (Genetic Alliance, UK).
Personalised Medicine: the promise, the hype and the pitfalls, a short interview with Mark Lawler A major conference exploring scientific, clinical, legal, ethical and social implications of biomarker-based personalised medicine. Speakers include Richard Barker (Centre for the Advancement of Sustainable Medical Innovation, Oxford), Steve Sturdy (Professor of the Sociology of Medical Knowledge, University of Edinburgh), Sian Rees (Oxford Academic Health Science Network; Director, Oxford Health Experiences Institute), Anna Middleton (Wellcome Trust Sanger Institute), Muir Gray (Better Value Healthcare), Alastair Kent (Genetic Alliance, UK).
Personalised Medicine: the promise, the hype and the pitfalls, a short interview with Alastair Kent A major conference exploring scientific, clinical, legal, ethical and social implications of biomarker-based personalised medicine. Speakers include Richard Barker (Centre for the Advancement of Sustainable Medical Innovation, Oxford), Steve Sturdy (Professor of the Sociology of Medical Knowledge, University of Edinburgh), Sian Rees (Oxford Academic Health Science Network; Director, Oxford Health Experiences Institute), Anna Middleton (Wellcome Trust Sanger Institute), Muir Gray (Better Value Healthcare), Alastair Kent (Genetic Alliance, UK).
Personalised Medicine: the promise, the hype and the pitfalls, a short interview with Rick Kaplan A major conference exploring scientific, clinical, legal, ethical and social implications of biomarker-based personalised medicine. Speakers include Richard Barker (Centre for the Advancement of Sustainable Medical Innovation, Oxford), Steve Sturdy (Professor of the Sociology of Medical Knowledge, University of Edinburgh), Sian Rees (Oxford Academic Health Science Network; Director, Oxford Health Experiences Institute), Anna Middleton (Wellcome Trust Sanger Institute), Muir Gray (Better Value Healthcare), Alastair Kent (Genetic Alliance, UK).
Personalised Medicine: the promise, the hype and the pitfalls, a short interview with Muir Gray A major conference exploring scientific, clinical, legal, ethical and social implications of biomarker-based personalised medicine. Speakers include Richard Barker (Centre for the Advancement of Sustainable Medical Innovation, Oxford), Steve Sturdy (Professor of the Sociology of Medical Knowledge, University of Edinburgh), Sian Rees (Oxford Academic Health Science Network; Director, Oxford Health Experiences Institute), Anna Middleton (Wellcome Trust Sanger Institute), Muir Gray (Better Value Healthcare), Alastair Kent (Genetic Alliance, UK).
Dr Andrew Papanikitas discusses markets and healthcare Dr Andrew Papanikitas (NIHR Academic Clinical Lecturer in General Practice, Nuffield Department of Primary Care Health Sciences, University of Oxford) discusses markets and healthcare as part of an event organised by Oxford Healthcare Values Parternship.
Dr Mahima Mitra discusses markets and healthcare Dr Mahima Mitra (Research Officer, Management in Medicine, Green Templeton College, University of Oxford) discusses markets and healthcare as part of an event organised by Oxford Healthcare Values Partnership.
Dr Anant Jani discusses markets and healthcare Dr Anant Jani (Executive Director Better Value Healthcare, Honorary Research Fellow Nuffield Department of Primary Care Health Sciences, University of Oxford) discusses markets and healthcare as part of an event organised by Oxford Healthcare Values Partnership.
Dr Jeremy Howick discusses empathy in healthcare Dr Jeremy Howick (Senior Research Fellow, Nuffield Department of Primary Care Health Sciences, University of Oxford) discusses empathy in healthcare as part of an event organised by the Oxford Healthcare Values Partnership.
Dr Therese Feiler discusses markets and healthcare Dr Therese Feiler (Wellcome Trust Postdoctoral Researcher, Oxford Healthcare Values Partnership, Faculty of Theology and Religion, University of Oxford) discusses markets and healthcare as part of an event organised by Oxford Healthcare Values Partnership.
Dr Joshua Hordern discusses personalised medicine Dr Joshua Hordern (Associate Professor of Christian Ethics, Faculty of Theology and Religion, University of Oxford) discusses personalised medicine as part of an event organised by Oxford Healthcare Values Partnership.